leisure time -WSS

leisure time

author：hotspot 2025-09-30 20:18:26 - browse：987

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： MoonLake credibility takes another hit with mid

WSS

Where does female orgasm come from? Scientists think they know

Doctors have an ethical obligation to be advocates

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Free speech concerns arise in wake of journal editor Eisen's firing

New requirements coming in 2024 for Americans traveling to Europe

My chronic pain journey would have been easier knowing 5 things % STAT

hotspot

leisure time

knowledge

Supreme Court strikes down use of affirmative action

Diversify hospital leadership teams to protect BIPOC patient health

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

White House calls on federal agencies to crack down on AI abuses

Apple is now the first public company to be valued at $3 trillion

The Sacklers, horror, and ‘The Fall of the House of Usher’

Medical records are filled with copy

Novartis develops a rapidly manufactured CAR

Virginia high school admissions case could be legal follow

Clinic falsely told dozens they had Alzheimer's, suits say

knowledge

MoonLake credibility takes another hit with mid

Novartis develops a rapidly manufactured CAR

Medicare solvency divides Republicans at the presidential debate

HPV cancer vaccine study demonstrates efficacy

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

focus

entertainment

entertainment

hotspot